Bristol-Myers Squibb (BMS) has announced its new-look leadership after the Celgene takeover goes through, and it reveals a mixed bag of new hires, sideways moves, and departures.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback